Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sean Ainsworth currently holds 321,692 shares of Ocuphire Pharma, Inc. (OCUP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sean Ainsworth has been a net neutral trader of OCUP stock. They have purchased $0 and sold $0 worth of shares.
Sean Ainsworth's most recent insider trade was on Apr 20, 2026, when they sold 24,367 shares at $0.00 per share.
Sean Ainsworth serves as Executive at Ocuphire Pharma, Inc. (OCUP). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Sean Ainsworth holds the position of Executive at Ocuphire Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Sean Ainsworth has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sean Ainsworth was on Aug 25, 2025, when they purchased $100.0K worth of IRD shares. This transaction involved 86,956 shares at $1.15 per share.
Sean Ainsworth currently owns 321,692 shares of Ocuphire Pharma, Inc. (OCUP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sean Ainsworth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sean Ainsworth has 10 Form 4 filings on record as an insider at Ocuphire Pharma, Inc..
Set alerts for Sean Ainsworth and 40,000+ other insiders.